Autism Spectrum Disorders Market Size And Forecast
Autism Spectrum Disorders Market size was valued at USD 3.25 Billion in 2019 and is projected to reach USD 4.53 Billion by 2027, growing at a CAGR of 4.27 % from 2020 to 2027.
The growing prevalence of autism and pervasive developmental disorder (PDD) and rising awareness about autism among the patient population is driving the global market. The growing awareness among the people through programs and initiatives will foster market growth. The Global Autism Spectrum Disorders Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Autism Spectrum Disorders Market Definition
Autism spectrum disorder (ASD) represents a group of neurodevelopmental disorders or disabilities; it is a heritable and polygenic disorder. Autism spectrum disorder is lifelong and typically emerges during early childhood. Children show ASD-related symptoms as early as 12 months of age, and symptoms change over time. The term “spectrum” is often associated with autism disorder as the disorder shows a wide variation in the type and severity of symptoms. Also, the combinations of several genetic variations contribute to the various forms of ASD.
The origins of ASD are not fully understood. However, common and rare inherited genetic variations along with non-inherited traits contribute to the development of ASD. According to DSM-5, patients with ASD face difficulties in social interaction, communication, activities, and nonverbal interactions; and show repetitive patterns of behaviours. ASD patients show high dependency on their routines, high sensitivity to their environment changes, or intense focus on inappropriate items presented before them. Although the disorder remains lifelong, early intervention results in symptoms improvement over a period of time. Early diagnosis ensures early intervention during the important developmental period.
Get | Download Sample Report @ https://www.verifiedmarketresearch.com/download-sample?rid=27067&utm_source=Free&utm_medium=004
Regular behavioural therapy might benefit the patients, especially with cognitive skills. Increased therapy procedures and awareness among people has resulted in positive care for such patients. Also, no specific medication for the treatment of autism is available. Medications are developed to ease some emotional and behavioural problems such as anxiety, irritability, anxiety, hyperactivity, aggression, depression, and others. Patients under medication are asked for their regular review to analyze the development of any side effects and treatment response.
Global Autism Spectrum Disorders Market Overview
The rising prevalence of patients with Autism Spectrum Disorders (ASD) has been the biggest driver of the market. Better public and medical awareness along with improved possibilities of diagnosing children at a young age have led to an increase in the prevalence of ASD. According to the data published in March 2020 by the Centers for Disease Control and Prevention (CDC)’s Autism and Developmental Disabilities Monitoring (ADDM) Network, nearly 1 in every 54 8-year-old children were identified as having ASD in 2016.
Also, the growing awareness of autism spectrum disorder (ASD) has encouraged early detection and diagnosis, therefore, allowing access to services to more children as early as possible. The rising number of awareness campaigns through various government initiatives across the globe has ensured the children suffering from ASD to have early access to evidence-based therapies. The growing awareness among the people through programs and initiatives is driving the global market. The increasing government funding and sponsored awareness programs, healthcare events for autism, followed by the innovation of new products, an increase in the number of autism patients, and growing research & development activities are boosting the global market.
Furthermore, the clinical trials and research studies currently underway are looking at new approaches to prevent, detect, or treat ASD and conditions. Various individual participants are invited to participate in the studies to determine the development of patients with and without autism. The number of clinical trials and research studies on ASD is likely to benefit the ASD market as new, coordinated and cost-effective approaches are being designed or will be designed for early screening, identification, and intervention in the disease. The studies are aiming to identify any patterns and correlations among ASD patients and their families.
Global Autism Spectrum Disorders Market: Segmentation Analysis
The Global Autism Spectrum Disorders Market is segmented on the basis of Type, Treatment Approach and Geography.
Autism Spectrum Disorders Market, By Type
• Autistic Disorder
• Asperger Syndrome
• Other Pervasive Developmental Disorders
Based on Type, the market is bifurcated into Autistic Disorder, Asperger Syndrome, PDD-NOS, and Other Pervasive Developmental Disorders. Autistic Disorder accounted for the largest market share in 2019. This type is considered the most severe and common form of autism. People who have autistic disorder are often hypersensitive and avoid contact with other people on many occasions. They tend to perform restricted or repetitive behaviours, experience sensory overload and may have issues communicating.
Autism Spectrum Disorders Market, By Treatment Approach
• Behavioural Approaches
• Early Intervention
Ask For Report Details @ https://www.verifiedmarketresearch.com/product/autism-spectrum-disorders-market/?utm_source=Free&utm_medium=004
On the basis of the Treatment Approach, the Global Autism Spectrum Disorders Market has been segmented into Behavioral Approaches, Early Intervention, Medication, and Others. Behavioural Approaches accounted for the largest market share in 2019. Behaviour and communication approaches are helpful for children suffering from ASD as these can provide structure, direction, and organization for the child in addition to family participation. These programs are typically highly structured and intensive and may involve the participation of parents, siblings, and other family members. Many behavioural programs address the range of social, language, and behavioural difficulties associated with ASD.
Autism Spectrum Disorders Market, By Geography
• North America
• Asia Pacific
• Rest of the world
On the basis of Geography, the Global Autism Spectrum Disorders Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is expected to hold the largest market share of Autism Spectrum Disorders over the forecast period. The prevalence of autism spectrum disorders (ASD) in North America is increasing. Based on tracking within 11 communities in the United States as a part of the ADDM Network, 1 in 54 8-year-old children were identified with ASD in 2016. The funding is expected to boost the research studies and clinical development of drugs and biomarkers through collaborations. Furthermore, autism therapy service providers are expanding their service reach in the United States to cater to the high demand for early diagnosis and intervention.
The “Global Autism Spectrum Disorders Market” study report will provide a valuable insight with an emphasis on the global market including some of the major players such as Johnson & Johnson Services, Inc, Bristol Myers Squibb, Otsuka Pharmaceutical Co., Ltd., Pfizer Inc, Roche Group, Allergan, Q BioMed Inc., AstraZeneca, Behavior Innovations, and Hopebridge, LLC. Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis.
For More Information @ https://www.verifiedmarketresearch.com/download-sample?rid=27067&utm_source=Free&utm_medium=004
About us –
Verified Market Research is a leading Global Research and Consulting firm that has been providing advanced analytical research solutions, custom consulting and in-depth data analysis for 10+ years to individuals and companies alike that are looking for accurate, reliable and up to date research data and technical consulting. VMR offers insights into strategic and growth analyses, Data necessary to achieve corporate goals and help make critical revenue decisions.
Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities and optimize efficiency by working as their partner to deliver accurate and valuable information. The industries we cover span over a large spectrum including Technology, Chemicals, Manufacturing, Energy, Food and Beverages, Automotive, Robotics, Packaging, Construction, Mining & Gas. Etc.
We, at Verified Market Research assist in understanding holistic market indicating factors and most current and future market trends. Our analysts, with their high expertise in data gathering and governance, utilize industry techniques to collate and examine data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject expertise and years of collective experience to produce informative and accurate research.
Having serviced over 5000+ clients, we have provided reliable market research services to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms like McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for businesses worldwide.
Mr. Edwyne Fernandes
Verified Market Research
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll-Free: +1 (800)-782-1768
Email: [email protected]
Try Our New Dashboard :-https://www.verifiedmarketresearch.com/dashboard/?utm_source=Free&utm_medium=004